**The Authors Reply:** Severe metabolic acidosis can generate detremental clinical effect such as cardiovascular depression and central nervous system dysfunction[@B1]. It also disturbe important key enzymes\' activity[@B2]. The effect of bocarbonate therapy aimed at correcting the pH, however, is controversial. Bicarbonate therapy produced CO~2~ and paradoxically lower the intracellular pH and cerebrospinal fluid pH[@B3], [@B4]. Bicarbonate infusion is associated with an increased blood lactate levels[@B4]. It might be also produce the volume expansion, hypernatremia and renbound alkalemia. The other buffer agents such as Carbicarb (Na~2~CO~3~ + NaHCO~3~) and THAM (Tris-hydroxymethyl aminomethane) are available, but these agents dose not imporving outcomes of metabolic acidosis[@B4].

Therefore, recent articles and text books suggest that therapy is aimed at correction of the underlying disorder, volume depletion, and electrolyte imbalance[@B4]-[@B6]. On condition that severe acidosis (pH \< 7.1) and the patient is deteriorating rapidly, bicarbonate therapy can be considered.
